Thomas Koudstaal

632 total citations · 1 hit paper
20 papers, 384 citations indexed

About

Thomas Koudstaal is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Rheumatology. According to data from OpenAlex, Thomas Koudstaal has authored 20 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Rheumatology. Recurrent topics in Thomas Koudstaal's work include Pulmonary Hypertension Research and Treatments (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Eosinophilic Disorders and Syndromes (3 papers). Thomas Koudstaal is often cited by papers focused on Pulmonary Hypertension Research and Treatments (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Eosinophilic Disorders and Syndromes (3 papers). Thomas Koudstaal collaborates with scholars based in Netherlands, Belgium and United Kingdom. Thomas Koudstaal's co-authors include Marlies Wijsenbeek, Karin A. Boomars, Philip L. Molyneaux, Manuela Funke-Chambour, Michael Kreuter, Mirjam Kool, Annemien E. van den Bosch, Laurie W. Geenen, Vivan J.M. Baggen and Rudi W. Hendriks and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and CHEST Journal.

In The Last Decade

Thomas Koudstaal

20 papers receiving 382 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pulmonary fibrosis: from pathogenesis to clinical decision-making

2023 103 citations Thomas Koudstaal, Manuela Funke-Chambour et al. Trends in Molecular Medicine profile →

Peers

Countries citing papers authored by Thomas Koudstaal

Since Specialization

Citations

This map shows the geographic impact of Thomas Koudstaal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Koudstaal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Koudstaal more than expected).

Fields of papers citing papers by Thomas Koudstaal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Koudstaal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Koudstaal. The network helps show where Thomas Koudstaal may publish in the future.

Co-authorship network of co-authors of Thomas Koudstaal

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Koudstaal. A scholar is included among the top collaborators of Thomas Koudstaal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Koudstaal. Thomas Koudstaal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic value of tricuspid valve regurgitation in patients with pulmonary arterial hypertension and CTEPH: A longitudinal study 2024 ·IJC Heart & Vasculature ·Kevin M. Veen, Thomas Koudstaal, (unknown), Johanna J.M. Takkenberg, Karin A. Boomars, Annemien E. van den Bosch	2
2	Predominance of M2 macrophages in organized thrombi in chronic thromboembolic pulmonary hypertension patients 2024 ·European Journal of Immunology ·Thomas Koudstaal, Thierry van den Bosch, Ingrid M. Bergen, (unknown), Paul Bresser, Harm Jan Bogaard, Karin A. Boomars, Rudi W. Hendriks, Jan H. von der Thüsen	3
3	Sexual Dysfunction in Patients With Sarcoidosis 2024 ·CHEST Journal ·Catharina C. Moor, (unknown), Thomas Koudstaal, Jelle Miedema	2
4	Idiopathic pulmonary fibrosis 2023 ·La Presse Médicale ·Thomas Koudstaal, Marlies Wijsenbeek	41
5	Pulmonary fibrosis: from pathogenesis to clinical decision-making breakdown → 2023 ·Trends in Molecular Medicine ·Thomas Koudstaal, Manuela Funke-Chambour, Michael Kreuter, Philip L. Molyneaux, Marlies Wijsenbeek	103
6	Evidence for a Role of CCR6+ T Cells in Chronic Thromboembolic Pulmonary Hypertension 2022 ·Frontiers in Immunology ·(unknown), Thomas Koudstaal, Jennifer A. C. van Hulst, Thierry P. P. van den Bosch, (unknown), Ingrid M. Bergen, (unknown), Annemien E. van den Bosch, Paul Bresser, Mirjam Kool, Jan H. von der Thüsen, Rudi W. Hendriks, Karin A. Boomars	7
7	Kynurenine metabolites predict survival in pulmonary arterial hypertension: A role for IL-6/IL-6Rα 2022 ·Scientific Reports ·(unknown), (unknown), Théo Klein, Ly Tu, Laurie W. Geenen, Thomas Koudstaal, Annemien E. van den Bosch, Yolanda B. de Rijke, Irwin Reiss, Eric Boersma, Claude van der Ley, Martijn van Faassen, Ido P. Kema, Dirk J. Duncker, Karin A. Boomars, Karin Tran‐Lundmark, Christophe Guignabert, Daphne Merkus	10
8	Peripheral Blood T Cells of Patients with IPAH Have a Reduced Cytokine-Producing Capacity 2022 ·International Journal of Molecular Sciences ·(unknown), Thomas Koudstaal, Jennifer A. C. van Hulst, (unknown), Menno van Nimwegen, Leon M. van den Toorn, (unknown), Annemien E. van den Bosch, Mirjam Kool, Rudi W. Hendriks, Karin A. Boomars	12
9	Plasma markers in pulmonary hypertension subgroups correlate with patient survival 2021 ·Respiratory Research ·Thomas Koudstaal, (unknown), Jennifer A. C. van Hulst, Peter Heukels, Ingrid M. Bergen, Laurie W. Geenen, Vivan J.M. Baggen, Annemien E. van den Bosch, Leon M. van den Toorn, (unknown), Mirjam Kool, Eric Boersma, Rudi W. Hendriks, Karin A. Boomars	27
10	Central Role of Dendritic Cells in Pulmonary Arterial Hypertension in Human and Mice 2021 ·International Journal of Molecular Sciences ·(unknown), Thomas Koudstaal, Jennifer A. C. van Hulst, Ingrid M. Bergen, (unknown), Nicholas W. Morrell, Geert Loo, Jan H. von der Thüsen, Thierry van den Bosch, Maria‐Rosa Ghigna, Frédéric Perros, David Montani, Mirjam Kool, Karin A. Boomars, Rudi W. Hendriks	15
11	Prevalence of Micronutrient Deficiencies and Relationship with Clinical and Patient-Related Outcomes in Pulmonary Hypertension Types I and IV 2021 ·Nutrients ·(unknown), Thomas Koudstaal, Femke Muskens, Annemien E. van den Bosch, Michiel G.J. Balvers, (unknown), Renger F. Witkamp, Klaske van Norren, Karin A. Boomars	12
12	DNGR1-Cre–mediated Deletion of Tnfaip3 /A20 in Conventional Dendritic Cells Induces Pulmonary Hypertension in Mice 2020 ·American Journal of Respiratory Cell and Molecular Biology ·Thomas Koudstaal, Jennifer A. C. van Hulst, (unknown), (unknown), Daphne Merkus, Ingrid M. Bergen, Michiel Alexander de Raaf, Harm Jan Bogaard, Louis Boon, Geert Loo, Joachim G.J.V. Aerts, Karin A. Boomars, Mirjam Kool, Rudi W. Hendriks	19
13	Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective 2020 ·Journal of Clinical Medicine ·Thomas Koudstaal, Karin A. Boomars, Mirjam Kool	35
14	Pulmonal-arterielle Hypertonie und chronisch-thromboembolische pulmonale Hypertonie: Eine immunologische Perspektive 2020 ·Thomas Koudstaal, Karin A. Boomars, Mirjam Kool	1
15	DNGR1-mediated deletion of A20/Tnfaip3 in dendritic cells alters T and B-cell homeostasis and promotes autoimmune liver pathology 2019 ·Journal of Autoimmunity ·(unknown), Ingrid M. Bergen, Thomas Koudstaal, Jennifer A. C. van Hulst, Geert Loo, André Boonstra, Thomas Vanwolleghem, Patrick S.C. Leung, M. Eric Gershwin, Rudi W. Hendriks, Mirjam Kool	13
16	The Effects of a 10-wk Outpatient Pulmonary Rehabilitation Program on Exercise Performance, Muscle Strength, Soluble Biomarkers, and Quality of Life in Patients With Pulmonary Hypertension 2019 ·Journal of Cardiopulmonary Rehabilitation and Prevention ·Thomas Koudstaal, Monique Wapenaar, Dirk van Ranst, (unknown), (unknown), Annemien E. van den Bosch, (unknown), Karin A. Boomars	14
17	Growth differentiation factor-15 as candidate predictor for mortality in adults with pulmonary hypertension 2019 ·Heart ·Laurie W. Geenen, Vivan J.M. Baggen, Robert M. Kauling, Thomas Koudstaal, Karin A. Boomars, Eric Boersma, Jolien W. Roos‐Hesselink, Annemien E. van den Bosch	21
18	Alterations in circulating helper T-cells in idiopathic pulmonary arterial hypertension 2019 ·(unknown), Menno van Nimwegen, Thomas Koudstaal, Peter Heukels, (unknown), Karin A. Boomars, Rudi W. Hendriks, Mirjam Kool	1
19	The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension 2019 ·Journal of Clinical Medicine ·Laurie W. Geenen, Vivan J.M. Baggen, Robert M. Kauling, Thomas Koudstaal, Karin A. Boomars, Eric Boersma, Jolien W. Roos‐Hesselink, Annemien E. van den Bosch	20
20	The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approach 2018 ·American Heart Journal ·Laurie W. Geenen, Vivan J.M. Baggen, Thomas Koudstaal, Karin A. Boomars, Jannet A. Eindhoven, Eric Boersma, Jolien W. Roos‐Hesselink, Annemien E. van den Bosch	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact